Results 31 to 40 of about 3,931 (193)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease

open access: yesPharmaceuticals, 2021
Chronic graft versus host disease (cGVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). It significantly decreases survival and quality of life.
Andrey Kozlov   +18 more
doaj   +1 more source

Graft-versus-host disease affecting oral cavity: a review [PDF]

open access: yes, 2015
Graft versus host disease (GVHD) is one of the most frequent and serious complications of hematopoietic stem cell transplantation, and is regarded as the leading cause of late mortality unrelated to the underlying malignant disease. GVHD is an autoimmune
Bagán Sebastián, José Vicente   +4 more
core   +1 more source

Lung transplantation in cystic fibrosis: Trends and controversies [PDF]

open access: yes, 2015
This article is not an overview of all facets of lung transplantation in cystic fibrosis (CF), but rather it is intended as a review of current allocation controversies, as well as of trends in diagnostics and management in lung transplant recipients and
Blatter, Joshua, Sweet, Stuart
core   +2 more sources

Heart re-transplantation in Eurotransplant [PDF]

open access: yes, 2018
Internationally 3% of the donor hearts are distributed to re-transplant patients. In Eurotransplant, only patients with a primary graft dysfunction (PGD) within 1 week after heart transplantation (HTX) are indicated for high urgency listing.
Baric, D. (Davor)   +30 more
core   +5 more sources

A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1/2 trial performed with optimized T-cell dosing. [PDF]

open access: yes, 2011
Studies of haploidentical hematopoietic stem cell transplantation (HSCT) have identified threshold doses of T cells below which severe GVHD is usually absent.
Brunner, Janet   +14 more
core   +2 more sources

Extracorporeal photopheresis in the treatment of graft-versus-host disease

open access: yesОнкогематология, 2016
Extracorporeal photopheresis has proved efficacy in the treatment of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation and is an alternative to other treatments.
I. V. Guz, P. E. Trachtman
doaj   +1 more source

Chronic lung allograft dysfunction following lung transplantation: Challenges and solutions [PDF]

open access: yes, 2014
Bradford C Bemiss, Chad A WittDepartment of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, St Louis, MO, USAAbstract: Chronic rejection is a major cause of death after the first year ...
Bemiss, Bradford C., Witt, Chad A.
core   +3 more sources

Bacterial contamination rates in extracorporeal photopheresis [PDF]

open access: yesTransfusion, 2020
ABSTRACTBACKGROUNDExtracorporeal photopheresis (ECP) is an immunosuppressive treatment that involves leukocyte apheresis, psoralen and UV light treatment, and subsequent reinfusion. Patients treated with ECP are usually immunosuppressed. Bacterial contamination therefore poses a much unwanted risk, but incidence data are lacking.PATIENTS AND METHODSWe ...
Irene Pamler   +7 more
openaire   +3 more sources

Extracorporeal Photopheresis in Dermatological Diseases. [PDF]

open access: yesInt J Mol Sci
Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as Sezary’s syndrome and mycosis fungoides. Over the past three decades, its immunotherapeutic properties have been tested on a variety of autoimmune conditions, including many ...
Terhaar H, Saleem M, Yusuf N.
europepmc   +3 more sources

Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA) [PDF]

open access: yes, 2022
Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity after allogeneic stem cell transplantation. Though perfect response rates are not achieved, steroids are still the first-line treat-ment.
Aksu, Salih   +6 more
core   +2 more sources

Home - About - Disclaimer - Privacy